You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三星醫療(601567.SH):擬推2024年核心團隊持股計劃
格隆匯 02-25 17:36

格隆匯2月25日丨三星醫療(601567.SH)公佈2024年核心團隊持股計劃,本持股計劃參加對象為公司及下屬公司董事(不含獨立董事)、高級管理人員、公司核心管理人員及骨幹人員,總人數不超過19人。其中,擬認購本持股計劃的公司董事和高級管理人員不超過4人,合計認購本持股計劃份額不超過1264.80萬份,佔本持股計劃總份額的30.00%;其他擬認購本持股計劃的員工不超過15人,合計擬認購持股計劃份額不超過2951.20萬份,佔本持股計劃總份額的70.00%。任何員工所獲股份權益對應的股票總數累計不超過公司股本總額的1%。

本持股計劃的資金總額不超過4216萬元,每1元為1份,資金來源為員工合法薪酬、業績獎金額度或法律法規允許的其他資金等。本持股計劃的股票來源為回購專用證券賬户中已回購的公司人民幣普通股(A股)股票。本持股計劃涉及的標的股票數量不超過204.86萬股,約佔公司現有股本的0.15%。本持股計劃實施後,公司已設立並存續的持股計劃所持有的股票總數累計不超過公司股本總額的10%,單個員工所獲股份權益對應的股票總數累計不超過公司股本總額的1%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account